Literature DB >> 1731610

Cleavage of proteoglycan aggregate by leucocyte elastase.

M T Mok1, M Z Ilic, C J Handley, H C Robinson.   

Abstract

The partial degradation of proteoglycan aggregate by human leucocyte elastase yielded products that banded with Mr 190,000, 140,000, 88,000, and 71,000 when analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide electrophoresis. Analysis of these bands revealed that the 190,000- and 140,000-Da bands contained chondroitin and keratan sulfate stubs and had N-terminal amino acid sequences corresponding to a sequence starting at residue 398 of the core protein of rat or human aggrecan. With increased time of digestion, the staining intensities of the 190,000-, 140,000-, and 88,000-Da bands decreased relative to the 71,000-Da band. Analysis of the 88,000- and 71,000-Da bands showed that they contained peptides substituted only with keratan sulfate stubs and that each band contained two peptides with different N-terminal sequences. One of these corresponded to a sequence that started at residue 398 of rat or human aggrecan and the other to the N-terminal sequence of bovine aggrecan. Under conditions of complete digestion, bands of 71,000 and 56,000 Da which contained only keratan sulfate stubs were observed on SDS-polyacrylamide electrophoresis. The 71,000-Da band was shown to have a single sequence similar to that starting at residue 398 of human and rat aggrecan and thus represents the globular domain 2 (G2) of the core protein of aggrecan. The 56,000-Da band was shown to have a sequence similar to that of the N-terminal sequence of bovine aggrecan indicating that this peptide corresponds to the globular domain 1 (G1) of the molecule. These results suggest that leucocyte elastase cleaves the core protein of aggrecan between valine 397 and isoleucine 398, which are located in the interglobular domain linking the G1 and G2 domains of the core protein of aggrecan. Further digestion of the proteoglycan aggregate with elastase resulted in the cleavage of the core protein within the chondroitin sulfate attachment domains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731610     DOI: 10.1016/0003-9861(92)90014-n

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  Mechanical and failure properties of extracellular matrix sheets as a function of structural protein composition.

Authors:  Lauren D Black; Philip G Allen; Shirley M Morris; Phillip J Stone; Béla Suki
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

2.  Characterization of proteoglycans isolated from associative extracts of human articular cartilage.

Authors:  V Vilím; A J Fosang
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

3.  High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.

Authors:  Rebecca E Wilusz; Farshid Guilak
Journal:  J Mech Behav Biomed Mater       Date:  2013-10-03

4.  Highly Aligned Nanofibrous Scaffold Derived from Decellularized Human Fibroblasts.

Authors:  Qi Xing; Caleb Vogt; Kam W Leong; Feng Zhao
Journal:  Adv Funct Mater       Date:  2014-05-28       Impact factor: 18.808

5.  Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.

Authors:  A J Fosang; K Last; P Gardiner; D C Jackson; L Brown
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

6.  The inhibitory effects of antirheumatic drugs on the activity of human leukocyte elastase and cathepsin G.

Authors:  J Steinmeyer; D A Kalbhen
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

7.  Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.

Authors:  A J Fosang; K Last; P J Neame; G Murphy; V Knäuper; H Tschesche; C E Hughes; B Caterson; T E Hardingham
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

8.  Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.

Authors:  M W Lark; H Williams; L A Hoernner; J Weidner; J M Ayala; C F Harper; A Christen; J Olszewski; Z Konteatis; R Webber
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

9.  Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls.

Authors:  N J Goodstone; M C Doran; R N Hobbs; R C Butler; J J Dixey; B A Ashton
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

10.  Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: characterization of naturally occurring hyaluronan-binding fragments of aggrecan.

Authors:  V Vilim; A J Fosang
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.